• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PVRI International Conference 2025: Embracing Heterogeneity.

作者信息

Singh Navneet, Zeder Katarina

机构信息

Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine Alpert School of Medicine at Brown University Providence Rhode Island USA.

Institute of Health Computing The University of Maryland Bethesda Maryland USA.

出版信息

Pulm Circ. 2025 May 1;15(2):e70093. doi: 10.1002/pul2.70093. eCollection 2025 Apr.

DOI:10.1002/pul2.70093
PMID:40321896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12045786/
Abstract
摘要

相似文献

1
PVRI International Conference 2025: Embracing Heterogeneity.2025年PVRI国际会议：拥抱异质性。
Pulm Circ. 2025 May 1;15(2):e70093. doi: 10.1002/pul2.70093. eCollection 2025 Apr.
2
Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension?肺血管阻力指数是否优于肺血管阻力预测肺动脉高压的结局？
J Heart Lung Transplant. 2021 Jul;40(7):614-622. doi: 10.1016/j.healun.2021.03.022. Epub 2021 Apr 2.
3
Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension.在已确诊肺动脉高压和有显性肺动脉高压风险的患者中，在超声心动图应激检查时肺血管储备减少。
Int J Cardiovasc Imaging. 2020 Oct;36(10):1831-1843. doi: 10.1007/s10554-020-01897-3. Epub 2020 May 27.
4
Reduced pulmonary arterial compliance predicts poor short-term outcome in children with pulmonary arterial hypertension independent of pulmonary vascular resistance.肺动脉顺应性降低预示着肺动脉高压患儿短期预后不良，且与肺血管阻力无关。
Front Cardiovasc Med. 2025 May 22;12:1526435. doi: 10.3389/fcvm.2025.1526435. eCollection 2025.
5
Use of Right Ventricular Free-Wall Strain in a Multivariable Estimate of Right Ventricular-Arterial Coupling in Pediatric Pulmonary Arterial Hypertension.右心室游离壁应变在小儿肺动脉高压右心室-动脉耦联多变量评估中的应用
Circ Cardiovasc Imaging. 2024 Dec;17(12):e016882. doi: 10.1161/CIRCIMAGING.124.016882. Epub 2024 Dec 17.
6
Endothelin-A receptor blockade in porcine pulmonary hypertension.内皮素 - A受体阻断在猪肺动脉高压中的作用
Pediatr Res. 2002 Dec;52(6):913-21. doi: 10.1203/00006450-200212000-00017.
7
Contemporary survival outcomes of congenital systemic-to-pulmonary shunt in children with borderline pulmonary vascular resistant index compared to Eisenmenger syndrome.与艾森曼格综合征相比，肺血管阻力指数临界值的先天性体肺分流患儿的当代生存结局。
Sci Rep. 2024 Jul 23;14(1):16867. doi: 10.1038/s41598-024-67899-6.
8
Pulmonary vascular resistance index: Getting the units right and why it matters.肺血管阻力指数：正确理解单位及其重要性
Clin Cardiol. 2019 Mar;42(3):334-338. doi: 10.1002/clc.23151. Epub 2019 Feb 27.
9
Comparative outcome of bidirectional Glenn shunt in patients with pulmonary vascular resistance > or = 3.5 woods units versus < 3.5 woods units.肺血管阻力≥3.5伍兹单位与＜3.5伍兹单位患者双向格林分流术的比较结果
Am J Cardiol. 2008 Oct 1;102(7):907-12. doi: 10.1016/j.amjcard.2008.04.063. Epub 2008 Jul 17.
10
Non-invasive determination by cardiovascular magnetic resonance of right ventricular-vascular coupling in children and adolescents with pulmonary hypertension.采用心血管磁共振对肺动脉高压儿童及青少年右心室-血管耦合进行无创测定。
J Cardiovasc Magn Reson. 2015 Sep 16;17(1):81. doi: 10.1186/s12968-015-0186-1.

本文引用的文献

1
Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.肺动脉高压的护理、治疗途径及疾病负担：拉丁美洲医生和患者的真实世界调查
BMJ Open. 2024 Dec 31;14(12):e087263. doi: 10.1136/bmjopen-2024-087263.
2
Polluted Air from Canadian Wildfires and Cardiopulmonary Disease in the Eastern US.来自加拿大野火的污染空气与美国东部的心肺疾病
JAMA Netw Open. 2024 Dec 2;7(12):e2450759. doi: 10.1001/jamanetworkopen.2024.50759.
3
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.慢性肺病相关肺动脉高压（PH-CLD）的筛查与诊断：肺血管研究所创新药物开发倡议-3型肺动脉高压共识声明
Pulm Circ. 2024 Dec 10;14(4):e70005. doi: 10.1002/pul2.70005. eCollection 2024 Oct.
4
Infection and pulmonary vascular diseases consortium: United against a global health challenge.感染与肺血管疾病联盟：携手应对全球健康挑战。
Pulm Circ. 2024 Nov 12;14(4):e70003. doi: 10.1002/pul2.70003. eCollection 2024 Oct.
5
Definition, classification and diagnosis of pulmonary hypertension.肺动脉高压的定义、分类和诊断。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01324-2024. Print 2024 Oct.
6
Risk stratification and treatment goals in pulmonary arterial hypertension.肺动脉高压的风险分层和治疗目标。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01323-2024. Print 2024 Oct.
7
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.肺动脉高压的临床试验设计、终点和新兴疗法。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01205-2024. Print 2024 Oct.
8
Artificial intelligence meets pulmonary hypertension: early detection for a late-presenting disease.人工智能与肺动脉高压：针对一种症状出现较晚的疾病进行早期检测
Eur Respir J. 2024 Jul 25;64(1). doi: 10.1183/13993003.01138-2024. Print 2024 Jul.
9
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension.人工智能在肺动脉高压表型分析的计算机断层扫描成像中的应用。
Curr Opin Pulm Med. 2024 Sep 1;30(5):464-472. doi: 10.1097/MCP.0000000000001103. Epub 2024 Jul 9.
10
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.各组肺动脉高压当代风险评分的比较：肺血管研究所 GoDeep 荟萃分析。
Chest. 2024 Sep;166(3):585-603. doi: 10.1016/j.chest.2024.03.018. Epub 2024 Mar 19.